Latest Articles Page 235 of 380
-
Short Communication June 27, 2022
P.1-2
J Cancer Immunol Ther: 5(3): 1-2
Importance of natural killer (NK) cells in therapy of cancer.
Author(s): Richard Bachman*
-
Research Article June 17, 2022
P.1-2
Hematol Blood Disord: 5(3): 1-2
Study of different fingerprint patterns in relation to gender and ABO blood groups among South Indian population.
Author(s): Faaizah Fathima*, Reshma Poothakulath Krishnan, Sandhya Sundar
-
Rapid Communication June 27, 2022
P.1-2
J Cancer Immunol Ther: 5(3): 1-2
Use of biomarkers, therapeutic treatment for hepatocellular carcinoma.
Author(s): Mark Twain*
-
Mini Review June 25, 2022
P.1-2
J Cancer Immunol Ther: 5(3): 1-2
Epidemiological aspects in controlling of cancer.
Author(s): Alan Gould*
-
Mini Review June 25, 2022
P.1-2
J Cancer Immunol Ther: 5(3): 1-2
Use of immunotherapies in the treatment of cancer patients.
Author(s): Calthorpe Strange
-
Research Article June 16, 2022
P.1-4
Hematol Blood Disord: 5(3): 1-4
Association of ABO blood group with oral cancer: An institutional study.
Author(s): Jagadheeswari Ramamoorthy*, Santhosh Kumar
-
Perspective November 30, -0001
P.1-2
Integr Neurosci Res: 5(5): 1-2
Cognitive behavioral therapy to patients with functional neurological disorders.
Author(s): Joseph Walker*
-
Mini Review November 30, -0001
P.1-2
Integr Neurosci Res: 5(5): 1-2
Characteristics of neuro-oncology patients after COVID-19 pandemic.
Author(s): Ronald Hoy*
-
Short Communication November 30, -0001
P.1-2
Integr Neurosci Res: 5(5): 1-2
Role of exercise and physical activity in neuro oncology patient.
Author(s): Franco Crook*
-
Opinion Article November 30, -0001
P.1-2
Integr Neurosci Res: 5(5): 1-2
Neurologic and cognitive outcome of life in adults after pneumococcal meningitis
Author(s): Jean Claire*